Crescent Capital BDC (NASDAQ:CCAP) CEO Jason Breaux Purchases 5,000 Shares of Company Stock

Crescent Capital BDC logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • CEO Jason Breaux bought 5,000 Crescent Capital BDC shares at an average price of $9.98, spending $49,900. The purchase increased his direct ownership by 9.5% to 57,636 shares.
  • The company reported quarterly EPS of $0.37, beating the $0.35 analyst consensus, and revenue of $36.89 million versus expectations of $36.37 million.
  • Crescent declared a quarterly dividend of $0.34 per share, equivalent to a 13.7% annualized yield at the reported share price. Analysts’ average rating was Hold, with an average price target of $11.54.
  • MarketBeat previews the top five stocks to own by December 1st.

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) CEO Jason Breaux acquired 5,000 shares of the company's stock in a transaction dated Tuesday, November 17th. The stock was bought at an average cost of $9.98 per share, for a total transaction of $49,900.00. Following the completion of the transaction, the chief executive officer directly owned 57,636 shares of the company's stock, valued at approximately $575,207.28. This trade represents a 9.50% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Crescent Capital BDC Stock Up 0.4%

Shares of NASDAQ CCAP traded up $0.04 during mid-day trading on Wednesday, reaching $9.92. 253,165 shares of the company were exchanged, compared to its average volume of 231,212. The company's 50-day simple moving average is $9.41 and its 200-day simple moving average is $11.43. The stock has a market capitalization of $365.55 million, a P/E ratio of -992.00 and a beta of 0.56. Crescent Capital BDC, Inc. has a twelve month low of $8.40 and a twelve month high of $15.18.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.02. The business had revenue of $36.89 million for the quarter, compared to analyst estimates of $36.37 million. Crescent Capital BDC had a negative net margin of 0.10% and a positive return on equity of 8.74%. As a group, equities research analysts expect that Crescent Capital BDC, Inc. will post 1.46 EPS for the current year.

Crescent Capital BDC Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Thursday, December 31st will be paid a dividend of $0.34 per share. The ex-dividend date is Thursday, December 31st. This represents a $1.36 dividend on an annualized basis and a dividend yield of 13.7%. Crescent Capital BDC's dividend payout ratio (DPR) is -13,600.00%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Condor Capital Management increased its holdings in Crescent Capital BDC by 0.7% in the 3rd quarter. Condor Capital Management now owns 281,799 shares of the company's stock worth $2,587,000 after purchasing an additional 1,840 shares in the last quarter. TT Capital Management LLC raised its position in Crescent Capital BDC by 9.2% in the third quarter. TT Capital Management LLC now owns 27,600 shares of the company's stock valued at $253,000 after purchasing an additional 2,333 shares during the last quarter. Aspen Grove Capital LLC boosted its stake in shares of Crescent Capital BDC by 0.9% during the first quarter. Aspen Grove Capital LLC now owns 269,852 shares of the company's stock valued at $3,279,000 after purchasing an additional 2,434 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of Crescent Capital BDC by 4.6% during the first quarter. Bank of America Corp DE now owns 59,551 shares of the company's stock valued at $724,000 after purchasing an additional 2,628 shares in the last quarter. Finally, Confluence Investment Management LLC boosted its stake in shares of Crescent Capital BDC by 9.9% during the second quarter. Confluence Investment Management LLC now owns 35,410 shares of the company's stock valued at $387,000 after purchasing an additional 3,187 shares in the last quarter. Institutional investors and hedge funds own 49.46% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on CCAP. Raymond James Financial set a $10.00 price target on Crescent Capital BDC in a report on Thursday, October 22nd. Wells Fargo & Company decreased their price objective on Crescent Capital BDC from $11.00 to $10.00 and set an "equal weight" rating on the stock in a report on Wednesday, November 11th. B. Riley Financial lowered their price objective on Crescent Capital BDC from $13.50 to $12.50 and set a "neutral" rating on the stock in a research report on Wednesday, August 12th. Ladenburg Thalmann & Co. Inc. downgraded Crescent Capital BDC from a "buy" rating to a "neutral" rating and set a $10.00 target price for the company. in a report on Wednesday, November 11th. Finally, Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and reduced their target price for the company from $13.00 to $12.00 in a research report on Monday, August 17th. Seven investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $11.54.

Get Our Latest Report on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market businesses. It is externally managed by Crescent Capital Group LP, an alternative credit investment manager. The company invests primarily in debt, including first- and second-lien senior secured loans and subordinated debt, and may also make equity investments. Its portfolio focuses mainly on U.S. companies. Crescent Capital BDC began investment operations in 2015. Through its financing activities, it aims to support the business needs of middle-market companies, including growth and other strategic initiatives.

Featured Stories

Insider Buying and Selling by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines